Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1275960

Role of galectin-3 in diagnosis and severity assessment of epicardial artery lesions in patients with suspected coronary artery disease


Bošnjak, Ivica; Bedeković, Dražen; Selthofer- Relatić, Kristina; Roguljić, Hrvoje; Mihaljević, Ivica; Bilić-Ćurčić, Ines
Role of galectin-3 in diagnosis and severity assessment of epicardial artery lesions in patients with suspected coronary artery disease // BMC Cardiovascular Disorders, 23 (2023), 268, 8 doi:10.1186/s12872-023-03310-y (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1275960 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Role of galectin-3 in diagnosis and severity assessment of epicardial artery lesions in patients with suspected coronary artery disease

Autori
Bošnjak, Ivica ; Bedeković, Dražen ; Selthofer- Relatić, Kristina ; Roguljić, Hrvoje ; Mihaljević, Ivica ; Bilić-Ćurčić, Ines

Izvornik
BMC Cardiovascular Disorders (1471-2261) 23 (2023); 268, 8

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Biomarker ; Chronic coronary syndrome ; Coronary artery disease ; Galectin-3

Sažetak
Background: This study aimed to investigate the possible role of serum galectin-3 (Gal-3) levels in the diagnosis and assessment of significant epicardial artery lesions in patients with suspected coronary artery disease (CAD). Methods: This was a single-center cross sectional cohort study including 168 subjects with suspected CAD and indications for coronary angiography divided into three groups: percutaneous coronary intervention (PCI) group (N 64), coronary artery bypass graft surgery (CABG) group (N 57), and group with no coronary stenosis (N 47). Gal-3 levels were measured and the syntax score (Ss) was calculated. Results: The mean value of Gal-3 in the PCI and CABG group was 19.98 ng/ml, while in the control group, it was 9.51 ng/ml (p < 0.001). The highest value of Gal-3 was found in the group of subjects with three-vessel disease (p < 0.001). When subgroups were analyzed by Gal-3 levels (< 17.8 ng/ml low, 18.8-25.9 ng/ml intermediate, > 25 ng/ml high risk) there was a significant difference between at least two Gal-3 groups for the arithmetic mean of Syntax score (p < 0.001). The syntax I's arithmetic mean at low and intermediate-risk Gal-3 levels was significantly lower than at high-risk Gal-3 levels (p < 0.001). Conclusion: Gal-3 could be used as an additional tool for diagnosis and severity assessment of atherosclerotic disease in patients with suspected CAD. Furthermore, it could help identify high-risk subjects in patients with stable CAD.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinički bolnički centar Osijek,
Medicinski fakultet, Osijek,
Fakultet za dentalnu medicinu i zdravstvo, Osijek

Poveznice na cjeloviti tekst rada:

doi www.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Bošnjak, Ivica; Bedeković, Dražen; Selthofer- Relatić, Kristina; Roguljić, Hrvoje; Mihaljević, Ivica; Bilić-Ćurčić, Ines
Role of galectin-3 in diagnosis and severity assessment of epicardial artery lesions in patients with suspected coronary artery disease // BMC Cardiovascular Disorders, 23 (2023), 268, 8 doi:10.1186/s12872-023-03310-y (međunarodna recenzija, članak, znanstveni)
Bošnjak, I., Bedeković, D., Selthofer- Relatić, K., Roguljić, H., Mihaljević, I. & Bilić-Ćurčić, I. (2023) Role of galectin-3 in diagnosis and severity assessment of epicardial artery lesions in patients with suspected coronary artery disease. BMC Cardiovascular Disorders, 23, 268, 8 doi:10.1186/s12872-023-03310-y.
@article{article, author = {Bo\v{s}njak, Ivica and Bedekovi\'{c}, Dra\v{z}en and Selthofer- Relati\'{c}, Kristina and Rogulji\'{c}, Hrvoje and Mihaljevi\'{c}, Ivica and Bili\'{c}-\'{C}ur\v{c}i\'{c}, Ines}, year = {2023}, pages = {8}, DOI = {10.1186/s12872-023-03310-y}, chapter = {268}, keywords = {Biomarker, Chronic coronary syndrome, Coronary artery disease, Galectin-3}, journal = {BMC Cardiovascular Disorders}, doi = {10.1186/s12872-023-03310-y}, volume = {23}, issn = {1471-2261}, title = {Role of galectin-3 in diagnosis and severity assessment of epicardial artery lesions in patients with suspected coronary artery disease}, keyword = {Biomarker, Chronic coronary syndrome, Coronary artery disease, Galectin-3}, chapternumber = {268} }
@article{article, author = {Bo\v{s}njak, Ivica and Bedekovi\'{c}, Dra\v{z}en and Selthofer- Relati\'{c}, Kristina and Rogulji\'{c}, Hrvoje and Mihaljevi\'{c}, Ivica and Bili\'{c}-\'{C}ur\v{c}i\'{c}, Ines}, year = {2023}, pages = {8}, DOI = {10.1186/s12872-023-03310-y}, chapter = {268}, keywords = {Biomarker, Chronic coronary syndrome, Coronary artery disease, Galectin-3}, journal = {BMC Cardiovascular Disorders}, doi = {10.1186/s12872-023-03310-y}, volume = {23}, issn = {1471-2261}, title = {Role of galectin-3 in diagnosis and severity assessment of epicardial artery lesions in patients with suspected coronary artery disease}, keyword = {Biomarker, Chronic coronary syndrome, Coronary artery disease, Galectin-3}, chapternumber = {268} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font